DIPROBETASON suspension is indicated for the treatment of acute and chronic corticosteroid-responsive disorders, corticosteroid hormone therapy is an adjunct to, and not a replacement for conventional therapy.

Musculoskeletal and soft tissue conditions: Rheumatoid arthritis, osteoarthritis, bursitis, ankylosing spondylitis, epicondylitis, radiculitis, sciatica, lumbago, torticollis, ganglion cyst, fasciitis.

Allergic conditions: Chronic bronchial asthma (including adjunctive therapy for status asthmaticus), hay fever, angioneurotic edema, allergic bronchitis, seasonal or perennial allergic rhinitis, drug reactions, serum sickness, insect bites.

Dermatologic conditions: Atopic dermatitis (nummular eczema), neurodermatitis (circumscribed lichen simplex), contact dermatitis, severe solar dermatitis, urticaria, discoid lupus erythematosus, psoriasis, keloids, pemphigus, dermatitis herpetiformis, cystic acne.

Collagen diseases: Disseminated lupus erythematosus, scleroderma, dermatomyositis, periarteritis nodose.

Neoplastic diseases: For palliative management of leukemias and lymphomas in adults, acute leukemia of childhood.

Other Conditions: Adrenogenital syndrome, ulcerative colitis, regional ileitis, sprue.

Podiatric conditions: (Bursitis under heloma durum, hallux rigidus, digitus quintet varus), affections requiring subconjunctival injection, corticosteroid-responsive blood dyscrasias, nephritis and nephrotic syndrome.
Primary or secondary adrenocortical insufficiency may be treated with DIPROBETASON suspension but should be supplement with mineralocorticoids, if applicable.

DIPROBETASON suspension is recommended for:
1- Intramuscular injection in conditions responsive to systemic corticosteroids.
2- Injection directly into the affected soft tissues where indicated.
3- Intra-articular and periarticular injection in arthritides.
4- Intralesional injection in various dermatologic conditions.
5- Local injection in certain inflammatory and cystic disorders of the foot.

Category:
Corticosteroid

Composition:
Betamethasone Dipropionate 5 mg+ betamethasone sodium phosphate 2 mg/ ml.

Pharmaceutical Form:
1 Ampoule / 2 ml.

Group:
Glucocorticoid ______________________________________________________________________________________________

Aleppo Pharmaceutical Company (ALPHA) is Syria's leading manufacturer and distributor of pharmaceutical products. Providing high quality products according to GMP requirements; regulations and ISO 9002 (Quality Management System).

Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical manufacturing, pharmaceutical companies, pharmaceutical sales.

If you have any questions about DIPROBETASON that have not been answered on this site send us an email or call ALPHA Pharmaceutical Industry at + 963-21-2122424.

Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria - DIPROBETASON. All rights reserved
Web Design by Syrian Web Solutions